Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients with High Grade Glioma

-
Investigator: Nicholas Butowski, MD
Sponsor: Schering-Plough Corporation

Location(s): United States

Description

RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with recurrent high-grade glioma.